Clinical Trials Logo

Coronary Heart Disease clinical trials

View clinical trials related to Coronary Heart Disease.

Filter by:

NCT ID: NCT03198091 Recruiting - Clinical trials for Coronary Heart Disease

Efficacy of Dun Ye Guan Xin Ning Tablet in Patients With Stable Angina Pectoris

Start date: March 30, 2017
Phase: N/A
Study type: Interventional

This registry is designed to investigate factors affecting the efficacy of Dun Ye Guan Xin Ning tablet on patients with stable angina. The potential hypothesis is that Dun Ye Guan Xin Ning has a better effect on different subgroup patients with certain characteristics.

NCT ID: NCT03189199 Not yet recruiting - Clinical trials for Coronary Heart Disease

A Registry Study on Safety Surveillance of Dazhuhongjingtian (a Chinese Medicine Injection) Used in China

Start date: June 19, 2017
Phase: N/A
Study type: Observational

The purpose of this study is to make a cohort event monitoring to see whether and how Dazhuhongjingtian injection in hospital results in adverse events or adverse drug reactions

NCT ID: NCT03133689 Active, not recruiting - Clinical trials for Coronary Heart Disease

Alcohol Consumption and Coronary Heart Disease Onset

Start date: March 1, 2017
Phase: N/A
Study type: Observational

The primary aim of this study is to examine if long-term patterns of alcohol consumption are associated with time-to-onset for incident coronary heart disease (fatal and non-fatal), using data from multiple cohorts.

NCT ID: NCT03125772 Completed - Type 2 Diabetes Clinical Trials

Trial on Safety & Performance of TAXUS Element vs. XIENCE Prime Stent in Treatment of Coronary Lesion in Diabetics

Tuxedo
Start date: June 2011
Phase: N/A
Study type: Interventional

The TUXEDO-India is a prospective, single blind, multi-center randomized clinical trial to assess the TAXUS Element™ in a consecutive population of diabetic patients with coronary artery disease undergoing coronary revascularization. Approximately 1,830 patients with single or multi lesion, multi vessel coronary artery or saphenous vein graft disease ranging in vessels ranging from 2.25 mm to 4.0 mm in diameter by visual estimate will be enrolled in a 1:1 randomization to TAXUS Element™ vs. XIENCE™ Prime in India at up to 50 clinical sites, to demonstrate the safety and effectiveness of TAXUS Element™ in an unrestricted population. Procedural Endpoints: - Device success, defined as attainment of < 30% residual stenosis of the target lesion (visual assessment) using the TAXUS Element™ or XIENCE™ Prime stent. - Lesion success defined as attainment of < 30% residual stenosis (visual assessment) using any percutaneous method. - Procedure success defined as lesion success without the occurrence of in-hospital MACE. - Procedure complication rate including composite and individual angiographic occurrence of dissection ≥B, distal embolization, no reflow, slow flow, abrupt closure, or perforation.

NCT ID: NCT03106116 Recruiting - Clinical trials for Coronary Heart Disease

Efficacy of Enhanced External Counterpulsation on Ventricular Function

EECPVF
Start date: March 15, 2017
Phase: N/A
Study type: Interventional

The purpose of this study is to investigate the efficacy of Enhanced External Counterpulsation (EECP) therapy on ventricular function in patients with coronary heart disease

NCT ID: NCT03102502 Recruiting - Clinical trials for Coronary Heart Disease

Impact of Enhanced External Counterpulsation on Vascular Hemodynamics and Status

EECPVHS
Start date: March 10, 2017
Phase: N/A
Study type: Interventional

The present study aimed to investigated the effect of Enhanced External Counterpulsation (EECP) on vascular hemodynamics and atherosclerosis, and the underlying shear stress related mechanisms

NCT ID: NCT03083119 Recruiting - Clinical trials for Coronary Heart Disease

Efficacy and Safety of Xuesaitong Soft Capsule for Coronary Heart Disease Unstable Angina

Start date: March 20, 2017
Phase: Phase 2
Study type: Interventional

In this study, typical cases of coronary heart disease are selected. They will be intervened by Xuesaitong soft capsules to investigate efficacy and safety for Coronary Heart disease.

NCT ID: NCT03076801 Not yet recruiting - Clinical trials for Myocardial Infarction

Does Choral Singing Help imprOve Stress in Patients With Ischemic HeaRt Disease?

CHOIR
Start date: September 2017
Phase: N/A
Study type: Interventional

This pilot randomized control trial will examine the role of choral singing on psychosocial stress and cardiovascular outcomes in patients with ischemic heart disease (IHD). The hypothesis is that choral singing will improve psychosocial stress in comparison to the control group and this may have an impact on rates of hospitalization, death, myocardial infarction and stroke in these patients.

NCT ID: NCT03067402 Not yet recruiting - Clinical trials for Coronary Artery Disease

Routine Or Selective Stress Testing After Revascularization: ROSSTAR Trial RCT Outline

ROSSTAR
Start date: March 20, 2017
Phase: N/A
Study type: Interventional

The ROSSTAR trial is a pragmatic trial that will directly compare the strategies of routine and selective stress imaging testing (with radionuclide imaging (RNI)) late after PCI or CABG in asymptomatic patients. The study will be a single center trial based at the Jewish General Hospital (JGH), a McGill University teaching hospital (Montreal, Quebec). A total of 1100 patients who are either >5 years post-CABG or >2 years post-PCI will be randomized. Half of the patients will be randomized to a routine RNI testing, and the other half to selective RNI testing.

NCT ID: NCT03051061 Recruiting - Atrial Fibrillation Clinical Trials

Effect of Antithrombotic Treatment in Patients With Both Coronary Heart Disease and Atrial Fibrillation

ACHDAF
Start date: February 1, 2017
Phase: N/A
Study type: Observational [Patient Registry]

The optimal antithrombotic treatment for Coronary Heart disease (CHD) patients combined with Atrial Fibrillation (AF) is the hotspot at present. Although the European and American guidelines have given a hand for us, there is absence of solid evidence-based data on the safety of antithrombotic therapy in Asian populations. Only a few clinical trials and registries are available to guide difficult clinical decision making in patients with combined AF and CHD,the investigators highlight the need for the rapid development of clinical trials to close the large gaps in evidence. This research aims to know the real-world use of antithrombotic treatment and clinical prognosis in Coronary Heart Disease patients complicated with Atrial Fibrillation.